BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ip JD, Kok KH, Chan WM, Chu AW, Wu WL, Yip CC, To WK, Tsang OT, Leung WS, Chik TS, Chan KH, Hung IF, Yuen KY, To KK. Intra-host non-synonymous diversity at a neutralizing antibody epitope of SARS-CoV-2 spike protein N-terminal domain. Clin Microbiol Infect 2021;27:1350.e1-5. [PMID: 33144203 DOI: 10.1016/j.cmi.2020.10.030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Khong K, Zhang R, Hung IF. The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What. Vaccines 2022;10:1924. [DOI: 10.3390/vaccines10111924] [Reference Citation Analysis]
2 Sidarovich A, Krüger N, Rocha C, Graichen L, Kempf A, Nehlmeier I, Lier M, Cossmann A, Stankov MV, Schulz SR, Behrens GMN, Jäck HM, Pöhlmann S, Hoffmann M. Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1. Viruses 2022;14. [PMID: 36366573 DOI: 10.3390/v14112475] [Reference Citation Analysis]
3 Liao YC, Chen FJ, Chuang MC, Wu HC, Ji WC, Yu GY, Huang TS. High-Integrity Sequencing of Spike Gene for SARS-CoV-2 Variant Determination. Int J Mol Sci 2022;23:3257. [PMID: 35328676 DOI: 10.3390/ijms23063257] [Reference Citation Analysis]
4 Colson P, Fantini J, Yahi N, Delerce J, Levasseur A, Fournier PE, Lagier JC, Raoult D, La Scola B. Limited spread of a rare spike E484K-harboring SARS-CoV-2 in Marseille, France. Arch Virol 2022. [PMID: 35083577 DOI: 10.1007/s00705-021-05331-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang R, Khong KW, Leung KY, Liu D, Fan Y, Lu L, Chan PC, Chen L, To KK, Chen H, Yuen KY, Chan KH, Hung IF. Antibody Response of BNT162b2 and CoronaVac Platforms in Recovered Individuals Previously Infected by COVID-19 against SARS-CoV-2 Wild Type and Delta Variant. Vaccines (Basel) 2021;9:1442. [PMID: 34960189 DOI: 10.3390/vaccines9121442] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
6 Yusof W, Irekeola AA, Wada Y, Engku Abd Rahman ENS, Ahmed N, Musa N, Khalid MF, Rahman ZA, Hassan R, Yusof NY, Yean Yean C. A Global Mutational Profile of SARS-CoV-2: A Systematic Review and Meta-Analysis of 368,316 COVID-19 Patients. Life (Basel) 2021;11:1224. [PMID: 34833100 DOI: 10.3390/life11111224] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
7 Kubik S, Arrigo N, Bonet J, Xu Z. Mutational Hotspot in the SARS-CoV-2 Spike Protein N-Terminal Domain Conferring Immune Escape Potential. Viruses 2021;13:2114. [PMID: 34834921 DOI: 10.3390/v13112114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 To KK, Li X, Lung DC, Ip JD, Chan WM, Chu AW, Yip CC, Chen JHK, Poon RW, Tsoi HW, Lai RW, To WK, Ren L, Li M, Cao Y, Xie XS, Jin DY, Yuen KY. False COVID-19 cases due to contamination by inactivated virus vaccine. Clin Infect Dis 2021:ciab684. [PMID: 34498683 DOI: 10.1093/cid/ciab684] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Kubik S, Arrigo N, Bonet J, Xu Z. Mutational hotspot in the SARS-CoV-2 Spike protein N-terminal domain conferring immune escape potential.. [DOI: 10.1101/2021.05.28.446137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Caixeta DC, Oliveira SW, Cardoso-Sousa L, Cunha TM, Goulart LR, Martins MM, Marin LM, Jardim ACG, Siqueira WL, Sabino-Silva R. One-Year Update on Salivary Diagnostic of COVID-19. Front Public Health 2021;9:589564. [PMID: 34150692 DOI: 10.3389/fpubh.2021.589564] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
11 Cavanaugh AM, Fortier S, Lewis P, Arora V, Johnson M, George K, Tobias J, Lunn S, Miller T, Thoroughman D, Spicer KB. COVID-19 Outbreak Associated with a SARS-CoV-2 R.1 Lineage Variant in a Skilled Nursing Facility After Vaccination Program - Kentucky, March 2021. MMWR Morb Mortal Wkly Rep 2021;70:639-43. [PMID: 33914720 DOI: 10.15585/mmwr.mm7017e2] [Cited by in Crossref: 95] [Cited by in F6Publishing: 94] [Article Influence: 47.5] [Reference Citation Analysis]
12 To KK, Sridhar S, Chiu KH, Hung DL, Li X, Hung IF, Tam AR, Chung TW, Chan JF, Zhang AJ, Cheng VC, Yuen KY. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. Emerg Microbes Infect 2021;10:507-35. [PMID: 33666147 DOI: 10.1080/22221751.2021.1898291] [Cited by in Crossref: 86] [Cited by in F6Publishing: 63] [Article Influence: 43.0] [Reference Citation Analysis]